deltatrials
Completed PHASE4 NCT00170222

Placebo Versus Antibiotics in Acute Exacerbations of Chronic Obstructive Pulmonary Disease (COPD)

The Value of Antibiotic Treatment of Exacerbations of Hospitalised COPD Patients

Sponsor: Medical Center Alkmaar

Conditions Chronic Obstructive Pulmonary Disease
Interventions doxycycline
Updated 5 times since 2017 Last updated: Sep 26, 2008 Started: Jul 31, 2002 Primary completion: Aug 31, 2008 Completion: Aug 31, 2008

Listed as NCT00170222, this PHASE4 trial focuses on Chronic Obstructive Pulmonary Disease and remains completed. Sponsored by Medical Center Alkmaar, it has been updated 5 times since 2002, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Change History

5 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE4

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE4

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE4

  4. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE4

  5. Jan 2017 — Jun 2018 [monthly]

    Completed PHASE4

    First recorded

Jul 2002

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Medical Center Alkmaar
Data source: Medical Center Alkmaar

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Alkmaar, Netherlands